Gene jam holds hope for leukaemia therapy

Brown, Phyllida
August 1991
New Scientist;8/10/91, Vol. 131 Issue 1781, p21
Reports that the gene that causes chronic myelogenous leukemia can be blocked in cancerous cells without damaging the healthy ones in the United States. Possibility of gene therapy for the disease Swap of genetic material between chromosomes 9 and 22; Pathology of the disease; Previous attempts to block the gene.


Related Articles

  • The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia. Xishan, Z; Xianjun, L; Ziying, L; Guangxin, C; Gang, L // Cancer Gene Therapy;Sep2014, Vol. 21 Issue 9, p397 

    The aim of this study was to investigate the role and mechanism of miR-23a in the regulation of BCR/ABL and to provide a new prognostic biomarker for chronic myeloid leukemia (CML). The expression levels of miR-23a and BCR/ABL were assessed in 42 newly diagnosed CML patients, 37 CML patients in...

  • Expression of endothelial cell-associated molecules in AML cells. Watarai, M.; Miwa, H.; Shikami, M.; Sugamura, K.; Wakabayashi, M.; Satoh, A.; Tsuboi, T.; Imamura, A.; Mihara, H.; Katoh, Y.; Kita, K.; Nitta, M. // Leukemia (08876924);Jan2002, Vol. 16 Issue 1, p112 

    Recently, it has been clarified that interaction between hematopoietic cells and endothelial cells is important in normal hematopoiesis and leukemogenesis. In this study, we examined the relationship between AML cells and endothelial cells by analyzing the expression profile of angiogenic...

  • Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses. Koya, R.C.; Kasahara, N.; Pullarkat, V.; Levine, A.M.; Stripecke, R. // Leukemia (08876924);Sep2002, Vol. 16 Issue 9, p1645 

    Acute myeloid leukemia (AML) patients treated with available therapies achieve remission in approximately 60% of cases, but the long-term event-free survival is less than 30%. Use of immunotherapy during remission is a potential approach to increase survival. We propose to develop cell vaccines...

  • The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors. Glowacki, Sylwester; Synowiec, Ewelina; Blasiak, Janusz // International Journal of Molecular Sciences;Aug2013, Vol. 14 Issue 8, p16348 

    Chronic myeloid leukemia (CML) is a hematological malignancy that arises from the transformation of stem hematopoietic cells by the fusion oncogene BCR/ABL and subsequent clonal expansion of BCR/ABL-positive progenitor leukemic cells. The BCR/ABL protein displays a constitutively increased...

  • FLT3 expression and IL10 promoter polymorphism in acute myeloid leukemia with RUNX1- RUNX1T1. Kim, Myungshin; Kim, Jiyeon; Kim, Jung; Han, Eunhee; Park, Joonhong; Lim, Jihyang; Kim, Yonggoo; Han, Kyungja; Kim, Hee-Je; Min, Woo-Sung; Cho, Bin // Molecular Biology Reports;Feb2015, Vol. 42 Issue 2, p451 

    We investigated the correlation between FLT3 expression and IL10 gene promoter polymorphism in acute myeloid leukemia with RUNX1- RUNX1T1 and their clinical significance. FLT3 mRNA expression was measured by real-time quantitative PCR (qPCR) and immunohistochemical staining (IHC) on bone marrow...

  • Spoken presentations.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS17 

    Discusses the abstract of the research paper entitled 'A distinct pattern of gene expression is highly correlated with the major cytogenetic subgroups in AML,' by Debra M. Lillington, B.D. Young and presented during the British Human Genetics Conference at the University of York in England in...

  • Poster presentations: 2. Cytogenetics.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS56 

    Discusses the abstract of the research paper entitled 'Mapping of a commonly-deleted region on chromosome 9q in myeloid leukaemia,' by Lucy Side, A.J. Peniket et al and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • Breakthrough identifies how mutated genes reprogram blood stem cells in leukemia.  // Oncology Nurse Advisor;Sep/Oct2015, Vol. 6 Issue 5, p12 

    No abstract available.

  • Backtracking to birth of the NUP98-HOXD13 gene fusion in an infant acute myeloid leukemia. Emerenciano, M.; Meyer, C.; Macedo-Silva, M. L.; de Meis, E.; Dobbin, J. A.; Marschalek, R.; Pombo-de-Oliveira, M. S. // Leukemia (08876924);Jul2011, Vol. 25 Issue 7, p1192 

    A letter to the editor is presented regarding a nine-month-old boy with acute myeloid leukemia (AML), who was found with a gene fusion transcript between the nuclear pore complex protein 98 kDa (NUP98) and the homeobox protein (HOXD13).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics